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Abstract Wnt5a-Ror signaling constitutes a developmental pathway crucial for embryonic tissue
morphogenesis, reproduction and adult tissue regeneration, yet the molecular mechanisms by
which the Wnt5a-Ror pathway mediates these processes are largely unknown. Using a proteomic
screen, we identify the kinesin superfamily protein Kif26b as a downstream target of the Wnt5a-Ror
pathway. Wnt5a-Ror, through a process independent of the canonical Wnt/b-catenin-dependent
pathway, regulates the cellular stability of Kif26b by inducing its degradation via the ubiquitin-
proteasome system. Through this mechanism, Kif26b modulates the migratory behavior of cultured
mesenchymal cells in a Wnt5a-dependent manner. Genetic perturbation of Kif26b function in vivo
caused embryonic axis malformations and depletion of primordial germ cells in the developing
gonad, two phenotypes characteristic of disrupted Wnt5a-Ror signaling. These findings indicate
that Kif26b links Wnt5a-Ror signaling to the control of morphogenetic cell and tissue behaviors in
vertebrates and reveal a new role for regulated proteolysis in noncanonical Wnt5a-Ror signal
transduction.
DOI: https://doi.org/10.7554/eLife.26509.001
Introduction
The Wnt family of extracellular signaling factors orchestrates diverse developmental processes dur-
ing both embryogenesis and adult tissue homeostasis. Dysfunction of Wnt signaling has been impli-
cated in many human diseases ranging from congenital birth defects to neoplasia (Clevers and
Nusse, 2012; Kikuchi et al., 2012). Wnt ligands achieve high functional versatility in part by
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activating multiple biochemically distinct pathways to regulate diverse cell biological processes
(Veeman et al., 2003; Semenov et al., 2007).
Unlike the well-characterized ‘canonical’ Wnt pathway that signals through the transcription co-
regulator b-catenin to induce target gene expression, a subset of Wnts signal independently of this
Wnt/b-catenin pathway via ‘noncanonical’ mechanisms to control cytoskeleton-driven morphoge-
netic events such as directed cell movements, changes in cell polarization and cell adhesion
(Moon et al., 1993; Veeman et al., 2003). The best-studied noncanonical Wnt, Wnt5a, is critical for
the proper morphogenesis of many tissues throughout the developing embryo (Moon et al., 1993;
Yamaguchi et al., 1999; Bodmer et al., 2009; Laird et al., 2011; Chawengsaksophak et al., 2012;
Miyoshi et al., 2012; Cha et al., 2014). Dysregulation of Wnt5a signaling leads to birth defects and
is associated with multiple pathological processes in the adult including cancer metastasis and
inflammatory diseases such as atherosclerosis (Kurayoshi et al., 2006; Da Forno et al., 2008;
Yamamoto et al., 2010; Jin et al., 2012; Lu et al., 2012; Bhatt and Malgor, 2014; Ford et al.,
2014; Lin et al., 2014; Lu et al., 2014; Qin et al., 2015).
A growing consensus suggests that the Ror family of receptor tyrosine kinases mediates Wnt5a-
dependent morphogenetic functions in the developing animal (Oishi et al., 2003; Green et al.,
2008a; Mikels et al., 2009; Ho et al., 2012). However, how Wnt5a signaling via Ror receptors
affects downstream cellular processes remains poorly understood. In a previous study, we found that
among the many biochemical activities previously proposed to be downstream of Wnt5a signaling,
only the phosphorylation of the cytoplasmic scaffolding protein Dishevelled (Dvl) required the
expression of both Wnt5a and Ror proteins (Ho et al., 2012). This finding suggested that Wnt5a-
Ror-dependent phosphorylation of Dvl specifically mediates the biological functions of Wnt5a signal-
ing and led us to propose that Ror and Dvl are key components of the noncanonical Wnt5a pathway.
The assignment of these proteins to a common pathway is further supported by the observation that
human mutations in WNT5A, ROR2, DVL1 and DVL3 can cause Robinow syndrome, a congenital dis-
order characterized by short-limbed dwarfism and morphological defects in craniofacial and genital
structures, demonstrating that the Wnt5a-Ror-Dvl pathway regulates morphogenesis during human
development (Afzal et al., 2000; van Bokhoven et al., 2000; Person et al., 2010; Bunn et al.,
2015; White et al., 2015, 2016). However, since the function of Dvl phosphorylation is not clear,
and Dvl is a common component of several signaling pathways including the canonical Wnt signaling
pathway and the planar cell polarity (PCP) pathway, how the Wnt5a-Ror pathway signals to carry out
its biological functions remains incompletely understood.
In this study, we conducted a whole phosphoproteome-scale mass spectrometric screen compar-
ing wild-type cells with cells lacking the Ror family of proteins in an effort to identify additional effec-
tors of Wnt5a-Ror signaling. The screen identified a number of candidate proteins whose levels or
phosphorylation status was influenced by Wnt5a-Ror signaling, including factors involved in cytoskel-
etal regulation and cell adhesion, processes crucial for the morphogenesis of tissues. We then
focused the remainder of the study on characterizing Kif26b, a member of the kinesin microtubule
motor superfamily, which stood out as a particularly promising target of Wnt5a-Ror signaling for the
following reasons. Mutations in the C. elegans orthologs of Ror and Kif26b produce similar neuronal
migration and axon guidance phenotypes, suggesting that these molecules might function in a com-
mon molecular pathway (Wightman et al., 1996; Forrester et al., 1998). Moreover, recent studies
demonstrated that Kif26b plays crucial roles in regulating cytoskeleton-driven processes, including
cell migration, polarization and adhesion, raising the possibility that Kif26b could function specifically
as a cytoskeletal effector of the Wnt5a-Ror pathway (Uchiyama et al., 2010; Guillabert-
Gourgues et al., 2016).
Through a series of biochemical studies, we demonstrate that Wnt5a-Ror signaling regulates the
steady-state abundance of Kif26b in cells via a mechanism involving the ubiquitin-proteasome sys-
tem that is independent of the canonical Wnt/b-catenin-dependent pathway. Importantly, gain- and
loss-of-function experiments in cultured mesenchymal cells indicate that Wnt5a-Ror-Kif26b signaling
modulates mesenchymal cell migration. We also find that perturbation of Kif26b function disrupts a
number of Wnt5a/Ror-dependent processes in vivo. For example, in developing zebrafish embryos,
mis-expression of Kif26b causes axis and craniofacial malformations, thus mirroring the effects of
mis-expression of Wnt5a or Ror in zebrafish. In developing mouse embryos, Kif26b expression is
required for primordial germ cells to populate the developing gonad, a process that also requires
the expression of Wnt5a or Ror proteins. Taken together, these findings establish Kif26b as a
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downstream effector of the noncanonical Wnt5a-Ror pathway that regulates cell and tissue behaviors
during development.
Results
A phosphoproteomic screen identifies Wnt5a-Ror signaling targets
We sought to discover downstream effectors of Wnt5a-Ror signaling, as these could provide insight
into the biochemical regulation and cell biological functions of the pathway. We reasoned that per-
turbation of upstream pathway components, such as the Ror receptors, would result in alterations in
the biochemical regulation of downstream effectors. To test this hypothesis, we took advantage of
primary mouse embryonic fibroblasts (MEFs) carrying conditional knockout alleles for the Ror1 and
Ror2 genes (Ho et al., 2012) and screened for biochemical changes that occur upon genetic ablation
of these genes. We previously showed that embryonic day 12.5 (E12.5) MEFs are a useful physiologi-
cally-relevant system for studying Wnt5a-Ror signaling. Not only are these cells derived from mesen-
chymal tissues that undergo active Wnt5a-Ror signaling in vivo, they continue to express high levels
of endogenous Wnt5a, Ror1, Ror2 and Dvl proteins in culture and undergo autocrine/paracrine
Wnt5a-Ror signaling without the addition of exogenous Wnt5a (Ho et al., 2012).
Using these conditional knockout MEFs, we performed a phosphoproteome-wide mass spectro-
metric screen to identify Ror-dependent changes in protein phosphorylation and/or abundance. Our
reasoning was that since Wnt5a signaling regulates the phosphorylation state of known downstream
components of the Wnt5a-Ror pathway, including Ror1, Ror2 and Dvl proteins (Bryja et al., 2007b;
Nishita et al., 2010; Grumolato et al., 2010; Ho et al., 2012) and microarray analysis of primary
MEFs lacking both Ror1 and Ror2 proteins failed to identify transcriptional changes relative to wild-
type cells, Wnt5a-Ror signaling likely affects cellular functions via a transcription-independent pro-
cess in MEFs (M.W.S., M.E.G., H.H.H. unpublished data).
To conduct the screen, we employed tandem mass tag (TMT) technology that enables the charac-
terization and quantification of peptides from six experimental conditions in a single, multiplexed
mass spectrometric (MS) analysis (Ting et al., 2011). This paradigm enabled the direct comparison
of the identity, abundance and post-translational modifications of proteins present in cells in which
the Ror proteins have been knocked out relative to wild-type control cells. Specifically, we analyzed
phosphopeptides isolated from MEFs derived from E12.5 Ror1f/f; Ror2f/f; CAG-CreER embryos. As
we described previously, the Ror1 and Ror2 conditional knockout alleles combined with the 4-
hydroxytamoxifen (4-OHT) inducible CAG-CreER allele enable the acute elimination of Ror1 and
Ror2 protein expression in vitro (Ho et al., 2012).
For the first four of the six experimental conditions analyzed in the MS screen, we derived MEFs
from two separate Ror1f/f; Ror2f/f; CAG-CreER embryos and treated each group with either 4-OHT
or a vehicle control (Figure 1A). 4-OHT treatment of Ror1f/f; Ror2f/f; CAG-CreER MEFs effectively
eliminated Ror1 and Ror2 protein expression, as measured by western blotting, and reduced the
phosphorylation of Dvl2, as measured by a motility shift of this protein on SDS-PAGE gels (Fig-
ure 1—figure supplement 1). This result confirmed the acute elimination of Ror1 and Ror2 protein
expression and a decrease in Wnt5a-Ror-Dvl signaling in both biological replicates analyzed in the
MS screen.
For the last two of the six experimental conditions in the screen, we cultured control MEFs from a
single Ror1+/+; Ror2+/+; CAG-CreER embryo and treated these cells with either 4-OHT or a vehicle
control to identify any nonspecific effects due to the addition of 4-OHT and the induction of Cre
recombinase expression (Figure 1A). As expected, treatment of these control cells with 4-OHT did
not alter the expression of Ror proteins or the phosphorylation of Dvl2, as compared with the vehicle
control (Figure 1—figure supplement 1). Together, the two experimental replicates and the control
condition allowed us to identify changes in the abundance of phosphorylated proteins and/or spe-
cific changes in protein phosphorylation events that are due to the disruption of Ror expression.
6498 unique phosphopeptides, representing 7426 distinct phosphosites, were quantified in the
screen (Supplementary file 1). For high confidence identification of biochemical changes that are
specific to the cells in which the Ror proteins were inducibly knocked out, phosphopeptides catego-
rized as ‘hits’ had to meet the following criteria: (1) an average of 2-fold increase or decrease in
the abundance of the phosphopeptide in 4-OHT-treated Ror1f/f; Ror2f/f; CAG-CreER MEFs relative
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Figure 1. Phosphoproteomic screen identifies putative targets of the Wnt5a-Ror pathway. (A) Experimental design of the six-plex mass spectrometry
analysis to screen for Ror-dependent biochemical cellular changes (see the main text for details of the experimental design). (B) Volcano plot of all
phosphopeptides identified and quantified in the experimental group. Significance (y-axis) is plotted against the average fold change (4-OHT/vehicle
treated samples) of the two biological replicates (x-axis). Significance values were generated with a two-sample t-test comparing values from the
Figure 1 continued on next page
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to vehicle-treated Ror1f/f; Ror2f/f; CAG-CreER MEFs; (2) a significant fold change (p<0.05) across
two experimental replicates; and (3) a <2-fold increase or decrease in the abundance of the phos-
phopeptide in 4-OHT-treated Ror1+/+; Ror2+/+; CAG-CreER MEFs relative to vehicle-treated Ror1+/
+; Ror2+/+; CAG-CreER MEFs. The 2-fold threshold was chosen to capture candidates whose change
in abundance ranked in the top 0.2 percent of all phosphopeptides analyzed in the screen.
Hits in this screen could reflect two possibilities: (1) Ror signaling mediates the phosphorylation
or dephosphorylation of a candidate protein, or (2) Ror signaling alters the total level of expression
of a candidate protein. The first possibility is more likely when a specific phosphorylated peptide
changes in abundance in a Ror-dependent manner while other phosphopeptides from the same pro-
tein do not change. The second possibility is more likely when each phosphorylated peptide from a
given protein increases or decreases in abundance in a Ror-dependent manner.
A total of fifteen unique phosphopeptides were identified as hits (Figure 1B and
Supplementary file 2). Eleven phosphopeptides increased in abundance and four phosphopeptides
decreased in abundance upon Ror depletion. Eight of the phosphopeptides that increased in abun-
dance mapped to the same protein—the kinesin superfamily member Kif26b—making it a high-con-
fidence candidate target of Wnt5a-Ror signaling (Figure 1B,C and Figure 1—figure supplement 2).
Moreover, all eight Kif26b phosphopeptides exhibited a significant increase in abundance following
genetic ablation of Ror expression in both experimental replicates (Figure 1B and
Supplementary file 2). Taken together, these observations strongly suggest that Wnt5a-Ror signal-
ing leads to a decrease in the level of Kif26b protein expression.
Kif26b is a downstream target of noncanonical Wnt5a-Ror signaling
Kif26b is a highly conserved atypical kinesin of the Kinesin-11 family, which includes Kif26a and
Kif26b, two proteins whose developmental and cellular functions have only begun to be revealed in
recent years (Uchiyama et al., 2010; Hirokawa and Tanaka, 2015; Guillabert-Gourgues et al.,
2016). To further test the hypothesis that Wnt5a-Ror signaling leads to a decrease in Kif26b protein
expression, as suggested by our MS screen, we generated polyclonal antibodies that specifically rec-
ognize the Kif26b protein. We validated the specificity of these antibodies by western blotting of
protein extracts obtained from wild-type MEFs, multiple Kif26b shRNA-knockdown MEFs or Kif26b-/-
MEFs (Figure 2—figure supplement 1A–C). We found that the anti-Kif26b antibodies recognized
protein bands at the predicted size of Kif26b (~220 kD) in wild-type MEF lysates but not in the
Kif26b knockout or knockdown MEF lysates, confirming that our antibodies specifically recognize
endogenous Kif26b.
Using these antibodies, we assessed the expression of Kif26b protein in primary MEFs in which
Ror1 and Ror2 proteins had been inducibly knocked out. We found that Kif26b levels were elevated
in Ror1f/f; Ror2f/f; CAG-CreER MEFs treated with 4-OHT as compared to MEFs with the same geno-
type treated with a vehicle control (Figure 2A). This finding suggests that Wnt5a-Ror signaling nega-
tively regulates total Kif26b protein expression, as opposed to selectively catalyzing the
dephosphorylation of multiple phosphorylation sites across the Kif26b protein. Moreover, this find-
ing validates that our MS screening approach reliably identifies cellular proteins whose expression is
regulated by Wnt5a-Ror signaling.
To test directly whether Wnt5a signaling regulates Kif26b protein levels, we assessed the expres-
sion of Kif26b in primary MEFs in which Wnt5a had been knocked out. We observed that Wnt5a-/-
Figure 1 continued
biological replicates. 6498 phosphopeptides were screened in each experiment. ‘Hit’ phosphopeptides, as defined in the text, are marked in blue. All
Kif26b phosphopeptides are circled in orange. (C) Volcano plot of all phosphopeptides identified and quantified in the control group. The fold change
(4-OHT/vehicle treated samples) is plotted along the x-axis. The position of the phosphopeptides along the y-axis is arbitrary, since there is only one
replicate of the control group and no significance value is calculated. Kif26b phosphopeptides are circled in orange.
DOI: https://doi.org/10.7554/eLife.26509.002
The following figure supplements are available for figure 1:
Figure supplement 1. Conditional depletion of Ror1 and Ror2 protein in MEFs.
DOI: https://doi.org/10.7554/eLife.26509.003
Figure supplement 2. Kif26b phosphorylation sites identified in the phosphoproteomic screen.
DOI: https://doi.org/10.7554/eLife.26509.004
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Figure 2. Kif26b protein levels are regulated by the expression of Wnt5a and Ror proteins in primary mouse embryonic fibroblasts. (A) Immunoblots of
Kif26b protein, Ror1 protein, Ror2 protein and Dvl2 protein in primary MEFs derived from two E12.5 Ror1f/f; Ror2f/f; CAG-CreER mice. 4-OHT or vehicle
control was added for 72 hr prior to lysis. Results of two independent biological replicates are shown. (B) Immunoblots of Kif26b protein, Ror1 protein,
Ror2 protein and Dvl2 protein in primary MEFs derived from littermate E12.5 Wnt5a+/+ and Wnt5a-/- mice. Results of two independent biological
Figure 2 continued on next page
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MEFs also had a higher level of Kif26b protein relative to wild-type control MEFs, indicating that
Wnt5a, like Ror1 and Ror2, negatively regulates the steady-state level of Kif26b expression
(Figure 2B). This finding suggests that Wnt5a signaling via Ror proteins leads to a decrease in
Kif26b protein expression.
We next investigated whether acute activation of Wnt5a-Ror signaling by the addition of exoge-
nous Wnt5a triggers a decrease in Kif26b protein expression in MEFs. We stimulated Wnt5a-/- MEFs
with purified, recombinant Wnt5a and found that this treatment led to a decrease in Kif26b protein
expression in a dose-dependent manner (Figure 2C). The decrease in Kif26b was accompanied by a
commensurate increase in Ror1 and Dvl2 phosphorylation, a readout of Wnt5a-Ror signaling
(Figure 2C). These findings suggest that Wnt5a induces the downregulation of endogenous Kif26b
expression as the Wnt5a-Ror-Dvl pathway becomes activated.
We found that the Wnt5a-induced downregulation of Kif26b expression is first detected 1 hr after
Wnt5a stimulation and that Kif26b expression is maximally decreased after 6 hr (Figure 2D). The
kinetics of Kif26b protein downregulation closely paralleled those of Ror1 and Dvl2 phosphorylation
in response to acute Wnt5a stimulation (Figure 2D), suggesting that Wnt5a signaling regulates these
downstream biochemical events in a coordinated manner. In addition, we found that stimulation
with Wnt5a does not change the level of Kif26b mRNA in Wnt5a-/- MEFs, as assayed by reverse tran-
scription-quantitative PCR (RT-qPCR), throughout the course of the experiment (Figure 2E), sug-
gesting that Wnt5a-dependent downregulation of Kif26b protein levels occurs post-transcriptionally.
Together, these findings establish that Wnt5a-Ror signaling leads to a decrease in the steady-state
levels of Kif26b protein expression in MEFs and validate Kif26b as a bona fide target of the Wnt5a-
Ror signaling pathway.
The Wnt5a-Ror pathway is generally thought to operate via a noncanonical, b-catenin-indepen-
dent mechanism (Green et al., 2008b). To determine whether Wnt5a-Ror signaling induces the
downregulation of Kif26b expression via a noncanonical Wnt signaling mechanism, we tested
whether blocking the canonical Wnt/b-catenin pathway with Dkk-1, an antagonist of the b-catenin-
dependent Wnt pathway that binds and prevents the phosphorylation of the canonical Wnt signaling
pathway co-receptors Lrp5 and Lrp6, inhibits the Wnt5a-induced decrease in Kif26b protein in MEFs
(Bafico et al., 2001). We found that exposure of Wnt5a-/- MEFs to exogenous Wnt5a protein
induced Kif26b downregulation to a similar degree with and without the addition of Dkk-1
(Figure 2F). To ensure that the Dkk-1 protein used in the experiment was active, we assessed
whether the same concentration of Dkk-1 was capable of blocking signaling by Wnt3a, a prototypic
canonical Wnt that induces the phosphorylation of the Wnt receptor Lrp6. We found that Wnt3a-
dependent phosphorylation of Lrp6 was completely blocked in the presence of Dkk-1 (Figure 2F).
Figure 2 continued
replicates are shown. (C) Immunoblots of Kif26b protein, Ror1 protein and Dvl2 protein in primary MEFs derived from E12.5 Wnt5a-/- mice. Recombinant
Wnt5a protein was added for 6 hr prior to lysis at the indicated dose. (D) Immunoblots of Kif26b protein, Ror1 protein and Dvl2 protein in primary MEFs
derived from E12.5 Wnt5a-/- mice. 0.1 mg/ml recombinant Wnt5a protein was added for the indicated amount of time prior to lysis. (E) Plot showing
relative mRNA expression of Kif26b and b-actin as measured by RT-qPCR in primary MEFs derived from E12.5 Wnt5a-/- mice, with 1 hr or 6 hr of Wnt5a
stimulation. The y-axis represents fold change relative to expression levels in unstimulated cells. Error bars represent ± SEM calculated from three
technical replicates. t-test (unpaired) was determined for the following comparisons: Kif26b 1 hr vs. 6 hr, p=0.249, not significant; b-actin 1 hr vs. 6 hr,
p=0.320, not significant. (F) Immunoblots of Kif26b protein and phospho-Lrp6 (serine 1490) protein in primary MEFs derived from E12.5 Wnt5a-/- mice.
Recombinant Dkk-1 (0.1 mg/ml) or vehicle control was added 8 hr prior to lysis. Recombinant Wnt3a protein, Wnt5a protein or vehicle control was
added for 6 hr prior to lysis. (G) Immunoblots of Kif26b protein in primary MEFs derived from E12.5 Wnt5a-/- mice. IWR-1 or vehicle control was added 7
hr prior to lysis. Recombinant Wnt3a protein, Wnt5a protein or vehicle control was added for 6 hr prior to lysis. a-tubulin was used for loading controls
in all experiments. All immunoblot samples were normalized by BCA assays for total protein.
DOI: https://doi.org/10.7554/eLife.26509.005
The following source data and figure supplement are available for figure 2:
Source data 1. (Related to panel E) Relative mRNA expression of Kif26b and b-actin as measured by RT-qPCR in primary MEFs derived from E12.5
Wnt5a-/- mice, after 1 hr or 6 hr of Wnt5a stimulation.
DOI: https://doi.org/10.7554/eLife.26509.007
Figure supplement 1. Validation of anti-Kif26b antibodies.
DOI: https://doi.org/10.7554/eLife.26509.006
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These findings suggest that Wnt5a-dependent regulation of Kif26b occurs via a noncanonical Wnt
signaling mechanism that is independent of the canonical Wnt/b-catenin pathway.
To verify that Wnt5a regulation of Kif26b occurs via a noncanonical Wnt signaling mechanism, we
next tested whether inhibiting the Wnt/b-catenin pathway at a more downstream step blocks
Wnt5a-dependent downregulation of Kif26b levels. For this purpose, we used IWR-1, a small mole-
cule that inhibits Wnt/b-catenin signaling by stabilizing Axin2, a key component of the b-catenin
destruction complex (Lee et al., 2003; Chen et al., 2009). Similar to our findings using Dkk-1 to
block the canonical Wnt/b-catenin pathway at the receptor level, we found that pre-treatment of
Wnt5a-/- MEFs with IWR-1 did not block the ability of Wnt5a or Wnt3a to induce the downregulation
of Kif26b protein expression (Figure 2G). These results further support the conclusion that Wnt5a-
Ror signaling leads to the downregulation of Kif26b protein expression via a noncanonical, b-cate-
nin-independent mechanism.
It is interesting to note that the addition of exogenous Wnt3a protein, classically considered a
canonical Wnt, also led to a decrease in the expression of Kif26b in Wnt5a-/- MEFs, even in the pres-
ence of Dkk-1 or IWR-1 (Figure 2F,G). These findings indicate that exogenous Wnt3a also signals via
a noncanonical Wnt signaling mechanism to downregulate the expression of Kif26b and supports
the emerging view that the distinction between canonical and noncanonical Wnt signaling is not
strictly determined at the level of Wnt ligands (van Amerongen et al., 2008). However, it is also
possible that there is some specificity to Wnt3a and Wnt5a signaling in the developing embryo that
is lost when these factors are studied using cultured MEFs.
Wnt5a signals the degradation of Kif26b via the ubiquitin-proteasome
pathway
We next investigated the biochemical mechanisms by which Wnt5a-Ror signaling leads to decreased
Kif26b protein expression. To more accurately quantify Kif26b levels in live cells, we developed a
flow cytometry-based reporter assay using NIH/3T3 cell lines stably expressing a GFP-Kif26b fusion
protein. We chose NIH/3T3 cells for the reporter assay because these cells express key components
of the Wnt5a-Ror pathway, including Ror1, Ror2, Dvl2 and Kif26b, which we found to be similarly
regulated by Wnt5a as in MEFs (Figure 3—figure supplement 1A,B). Furthermore, NIH/3T3 cells
are an immortalized cell line derived from mouse embryonic mesenchymal cells that undergo mor-
phogenetic movements during development (Todaro and Green, 1963), and they have been used
previously to study cell behaviors in the context of Wnt5a-Ror signaling (Endo et al., 2012). Western
analysis and immunostaining of these NIH/3T3 cell lines confirmed that the GFP-Kif26b protein is
stably expressed in these cells (Figure 3—figure supplement 2A–C).
Given that Wnt5a signaling acutely downregulates the level of endogenous Kif26b expression in
MEFs, we tested whether Wnt5a similarly downregulates GFP-Kif26b levels in the reporter NIH/3T3
cells. Treatment of these cells with exogenous recombinant Wnt5a protein induced an approximately
50% decrease in GFP-Kif26b expression as detected by three independent methods: flow cytometry
(Figure 3A), western analysis (Figure 3—figure supplement 2A) and time-lapse microscopy
(Video 1). These results indicate that Wnt5a treatment leads to a decrease in GFP-Kif26b in NIH/3T3
cells similar to that observed for endogenous Kif26b in MEFs, and that the GFP-Kif26b reporter can
be used reliably to monitor the decrease in Kif26b protein expression in response to Wnt5a signal-
ing. To the best of our knowledge, this is the first fluorescence-based reporter for real-time measure-
ment of a non-transcriptional Wnt5a-Ror signaling response in live cells. For the remainder of this
article, the Wnt5a-Ror-Kif26b reporter assay will be referred to as the WRK reporter assay.
We next used the WRK reporter assay in conjunction with flow cytometry to determine the dose-
response relationship between Wnt5a and GFP-Kif26b. We found that nanomolar amounts of Wnt5a
induced the downregulation of GFP-Kif26b expression with a calculated EC50 of 79.8 ng/ml (or 2.1
nM; Figure 3B). This response to Wnt5a occurs at a Wnt5a concentration that is similar to that of
other previously reported Wnt-induced cellular responses (Bryja et al., 2007a, 2007b; Witze et al.,
2008; Ho et al., 2012; van Amerongen et al., 2012; Witze et al., 2013; Park et al., 2015;
Connacher et al., 2017), suggesting that Wnt5a-induced Kif26b downregulation is a physiologically
relevant response to Wnt5a.
Wnt5a-Ror signaling could downregulate the steady state level of Kif26b protein either by
decreasing Kif26b synthesis or by increasing Kif26b turnover. Given that exposure of fibroblasts to
Wnt5a leads to a decrease in Kif26b expression over minutes to hours but does not lead to a
Susman et al. eLife 2017;6:e26509. DOI: https://doi.org/10.7554/eLife.26509 8 of 32
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Figure 3. Wnt5a downregulates Kif26b levels via a ubiquitin/proteasome-dependent mechanism. (A) Flow cytometry histograms depicting the
downregulation of GFP-Kif26b fluorescence in the WRK reporter cell line after Wnt5a stimulation (0.2 mg/ml Wnt5a) for 6 hr. (B) Dose-response curve
showing GFP-Kif26b downregulation as a function of Wnt5a concentration, as measured in the WRK reporter assay. (C) The kinetics of GFP-Kif26b
turnover in the absence or presence of Wnt5a stimulation, as measured in the WRK reporter assay. Cycloheximide was used to block new protein
synthesis in the reporter cells. (D) Flow cytometry histograms depicting the effect of epoxomicin treatment (1 mM) on the ability of Wnt5a (0.2 mg/ml) to
downregulate GFP-Kif26b fluorescence in the WRK reporter assay. DMSO was used as the drug vehicle control. (E) Flow cytometry histograms
depicting the effect of PYR-41 treatment (50 mM) on the ability of Wnt5a (0.2 mg/ml) to downregulate GFP-Kif26b fluorescence in the WRK reporter
assay. DMSO was used as the drug vehicle control. (F) Quantification of the effects of DMSO, epoxomicin and PYR-41 on the ability of Wnt5a to
downreagulate GFP-Kif26b fluorescence in the WRK reporter assay, as shown in (D) and (E). Error bars represent ± SEM calculated from three technical
replicates. t-tests were determined for the following comparisons: DMSO vs. epoxomicin, p<0.001; DMSO vs. PYR-41, p<0.001.
DOI: https://doi.org/10.7554/eLife.26509.008
The following source data and figure supplements are available for figure 3:
Source data 1. (Related to panel C) The kinetics of GFP-Kif26b turnover in the absence or presence of Wnt5a stimulation.
DOI: https://doi.org/10.7554/eLife.26509.011
Source data 2. (Related to panel F) The effects of DMSO, epoxomicin and PYR-41 on the ability of Wnt5a to downregulate GFP-Kif26b fluorescence in
the WRK reporter assay.
DOI: https://doi.org/10.7554/eLife.26509.012
Figure supplement 1. Expression of Wnt5a-Ror signaling components in MEFs and NIH/3T3 cells.
DOI: https://doi.org/10.7554/eLife.26509.009
Figure supplement 2. Characterization of the GFP-Kif26b (WRK) reporter line.
DOI: https://doi.org/10.7554/eLife.26509.010
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reduction in the level of Kif26b mRNA
(Figure 2D,E), we favored the latter possibility.
To directly measure the rate of Kif26b turnover,
we treated WRK reporter cells with cyclohexi-
mide to block new protein synthesis and then
used flow cytometry to measure the effect of
Wnt5a treatment on the rate of GFP-Kif26b turn-
over. Consistent with the hypothesis that Wnt5a
treatment leads to the increased degradation of
Kif26b, we found that Wnt5a accelerated the
turnover of GFP-Kif26b in the reporter cells
(Figure 3C). In the absence of Wnt5a stimulation,
80.2% of the GFP-Kif26b signal remained in the
cells 6 hr after the initiation of the cycloheximide
treatment. By contrast, in the presence of Wnt5a
stimulation, only 33.2% of the GFP-Kif26b signal
remained in the same period. These results
strongly suggest that Wnt5a treatment leads to a
decrease in the steady-state levels of Kif26b expression in cells by promoting Kif26b turnover.
We next investigated whether Wnt5a downregulates Kif26b expression by increasing the rate of
Kif26b degradation via the ubiquitin-proteasome system (UPS). To test this hypothesis, we asked
whether a selective inhibitor of the proteasome, epoxomicin, blocks downregulation of Kif26b
expression in response to Wnt5a (Meng et al., 1999). Pre-treatment of the WRK reporter line with
epoxomicin strongly blocked Wnt5a-induced Kif26b downregulation (Figure 3D,F). This result sug-
gests that Wnt5a-induced downregulation of Kif26b occurs via proteasome-dependent degradation.
To determine whether protein ubiquitination is specifically required for Wnt5a-induced Kif26b
degradation, we tested whether an inhibitor of the E1 enzyme required for ubiquitin activation, PYR-
41, also blocks Wnt5a-induced Kif26b downregulation (Yang et al., 2007). Pre-treatment of the
WRK reporter cells with PYR-41 blocked Wnt5a-induced Kif26b downregulation to an extent similar
to that observed upon epoxomicin treatment (Figure 3E,F). This finding provides further evidence
that downregulation of Kif26b expression induced by Wnt5a occurs via the UPS. We conclude from
these results that exposure to Wnt5a leads to the downregulation of the steady-state levels of
Kif26b expression by promoting Kif26b ubiquitin- and proteasome-dependent degradation.
Frizzled and Dishevelled proteins mediate Wnt5a-induced Kif26b
degradation
Our pharmacological inhibitor experiments suggest that the WRK reporter assay might be used to
interrogate other molecular components of the Wnt5a-Ror signaling pathway that operate upstream
of Kif26b. To test this idea, we first investigated a possible role of Frizzled (Fzd) proteins in Wnt5a-
dependent Kif26b degradation. Fzds make up a family of 10 seven-transmembrane domain receptor
proteins that function as co-receptors in canonical Wnt/b-catenin signaling and as polarity determi-
nants in the PCP pathway (Vinson and Adler, 1987; Bhanot et al., 1996). Recent work additionally
implicates Fzd proteins in aspects of noncanonical Wnt function as well as in the phosphorylation of
Ror2 in cultured cells (Habas et al., 2001; Nishita et al., 2010; Grumolato et al., 2010; Sato et al.,
2010). Moreover, protein sequence homology analysis and in vivo mouse genetic studies revealed
that Fzd1, Fzd2 and Fzd7 form a distinct sub-family that functions redundantly to control tissue mor-
phogenetic events such as convergent extension of embryonic tissues and closure of the palate and
ventricular septum (Yu et al., 2010; Yu et al., 2012). As many of these developmental processes
also require the Wnt5a-Ror pathway, we hypothesized that certain Fzd proteins, such as those in the
Fzd1, Fzd2 and Fzd7 sub-family, might participate in Wnt5a-Ror-Kif26b signaling.
To test whether Fzd proteins mediate Wnt5a-Ror-Kif26b signaling, we first took a loss-of-function
approach using Shisa proteins, which are Wnt signaling regulators that inhibit Fzd processing and
trafficking by sequestering Fzds in the endoplasmic reticulum (Yamamoto et al., 2005). We found
that viral transduction of Shisa2 expression, but not Cas9 expression as a control, partially blocked
the ability of Wnt5a to induce Kif26b degradation in the WRK reporter cell line (Figure 4A,B). This
observation suggests that the Fzd family plays a role in Wnt5a-dependent regulation of Kif26b.
Video 1. Time-lapse fluorescent confocal microscopy
reveals rapid Wnt5a-dependent downregulation of the
GFP-Kif26b signal in the NIH/3T3 reporter cell line.
Bright signal reflects GFP-Kif26b fluorescence. Buffer or
0.2 mg/mL recombinant Wnt5a was added at the start
of the imaging session. Cells were imaged every 10 min
for 16 hr at 40x magnification.
DOI: https://doi.org/10.7554/eLife.26509.013
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Figure 4. Involvement of Fzd and Dvl proteins in Kif26b degradation. (A) Flow cytometry histograms depicting the
effect of ectopic Shisa2 expression on the ability of Wnt5a to induce GFP-Kif26b degradation in the WRK reporter
assay. Mouse Shisa2 was expressed via lentiviral transduction. A lentivirus expressing Cas9 was used as the
control. The effect of Wnt5a or control buffer treatment on the WRK reporter line without virus infection is shown
as a reference. (B) Quantification of effects of the control virus (Cas9) and the Shisa2 virus on the ability of Wnt5a
to downregulate the GFP-Kif26b fluorescence in the WRK reporter assay, as shown in (A). Error bars
represent ± SEM calculated from three technical replicates. t-tests were determined for the following comparisons:
control virus vs. Shisa2 virus, p<0.001; control virus vs. no virus, p=0.0957 (not significant). (C) Flow cytometry
Figure 4 continued on next page
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To more directly test the involvement of Fzds in Wnt5a-Kif26b signaling, we asked whether over-
expression of Fzds could induce Kif26b degradation in the absence of exogenously added Wnt5a.
We first focused on members of the Fzd1, Fzd2 and Fzd7 sub-family, as the mouse knockout pheno-
types of these Fzds are most consistent with a functional interaction with the Wnt5a-Ror pathway
(Yu et al., 2010; Yu et al., 2012). Interestingly, we found that lentiviral transduction of Fzd1 or Fzd7
expression, but not of the negative control Cas9, constitutively induced Kif26b degradation as mea-
sured in the WRK assay (Figure 4C,D). This finding, taken together with the decreased Wnt5a-Ror-
Kif26b signaling upon expression of the Fzd inhibitor Shisa2, strongly suggests that Fzd family pro-
teins are involved in Wnt5a regulation of Kif26b degradation, possibly as co-receptors together with
members of the Ror family of proteins.
We also considered the possibility that functional specificity might exist among the different Fzd
sub-families. We therefore used the WRK assay to test multiple members from each Fzd sub-family,
as defined previously (Yu et al., 2010; Yu et al., 2012). Interestingly, we found that all the Fzd family
members that we tested were able to induce Kif26b degradation (Figure 4—figure supplement 1).
However, it is possible that the specificity of Fzd protein function is lost when these proteins are
overexpressed.
We next investigated the role of Dvl proteins in Wnt5a-Ror-dependent Kif26b degradation. Our
previous study identified Dvl phosphorylation as a specific downstream target of Wnt5a-Ror signal-
ing (Ho et al., 2012), and a recent study demonstrated that the Dvl and Kif26b proteins physically
interact (Guillabert-Gourgues et al., 2016). Moreover, we found that Wnt5a-induced Kif26b degra-
dation occurs with similar kinetics as Wnt5a-induced Dvl phosphorylation (Figure 2D). However, it
remains unknown whether Dvl proteins are required for Wnt5a-dependent degradation of Kif26b.
Since the presence of three Dvl genes in the mammalian genome makes loss-of-function analysis of
Dvl proteins challenging, we took a gain-of-function approach to determine if Dvl protein expression
affects Wnt5a-Ror-dependent Kif26b degradation. Notably, a similar overexpression approach was
previously used to demonstrate a role for Dvl proteins in Wnt/b-catenin signaling, as overexpression
of Dvl proteins in Xenopus embryos induces axis duplication recapitulating overexpression of canoni-
cal Wnts (Sokol et al., 1995). Using the WRK reporter assay, we found that overexpression of Dvl1,
but not overexpression of a control protein Cas9, led to an increase in Kif26b degradation
(Figure 4E,F), mimicking the effects of Wnt5a stimulation or Fzd overexpression. Taken together,
Figure 4 continued
histograms depicting the effect of ectopic Fzd1 or Fzd7 expression on GFP-Kif26b levels in the WRK reporter
assay. Mouse Fzd1 and Fzd7 were expressed via lentiviral transduction. A lentivirus expressing Cas9 was used as
the control. (D) Quantification of the median GFP-Kif26b fluorescence in the WRK reporter cell line infected with a
Fzd1 virus, a Fzd7 virus, or a Cas9 control virus. Error bars represent ± SEM calculated from six technical replicates.
t-tests were determined for the following comparisons: control virus vs. Fzd1 virus, p<0.001; control virus vs. Fzd7
virus, p<0.001. (E) Flow cytometry histograms depicting the effect of ectopic Dvl1 expression on GFP-Kif26b levels
in the WRK reporter assay. Dvl1 was expressed via lentiviral transduction. A lentivirus expressing Cas9 was used as
the control. (F) Quantification of the median GFP-Kif26b fluorescence in the WRK reporter cell line infected with a
Dvl1-expressing virus, or a Cas9-expressing control virus. Error bars represent ± SEM calculated from three
technical replicates. t-test was determined for control virus vs. Dvl1 virus, p<0.001.
DOI: https://doi.org/10.7554/eLife.26509.014
The following source data and figure supplement are available for figure 4:
Source data 1. (Related to panel B) The effects of the control virus and the Shisa2 virus on the ability of Wnt5a to
downregulate GFP-Kif26b fluorescence in the WRK reporter assay.
DOI: https://doi.org/10.7554/eLife.26509.016
Source data 2. (Related to panel D) The median GFP-Kif26b fluorescence in the WRK reporter cell line infected
with a Fzd1 virus, a Fzd7 virus, or a Cas9 control virus.
DOI: https://doi.org/10.7554/eLife.26509.017
Source data 3. (Related to panel F) Quantification of the median GFP-Kif26b fluorescence in the WRK reporter
cell line infected with a Dvl1 virus or a Cas9 control virus.
DOI: https://doi.org/10.7554/eLife.26509.018
Figure supplement 1. Comparison of the abilities of distinct Fzd subfamily members to induce Kif26b
degradation.
DOI: https://doi.org/10.7554/eLife.26509.015
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these findings establish a functional role for both Fzd receptors and Dvl1 (and likely other Dvl pro-
teins) in Wnt5a-Ror-dependent Kif26b degradation.
The Wnt5a-Ror-Kif26b signaling cassette directs the migratory behavior
of cells
Genetic studies in C. elegans have shown that mutations in the nematode orthologs of Kif26b (vab-
8) and Ror (cam-1) cause similar polarized cell migration and axon guidance phenotypes, and a
recent study in human umbilical vein endothelial cells (HUVECs) demonstrates a physical interaction
between Kif26b and Dvl3 (Forrester et al., 1998; Wolf et al., 1998; Chien et al., 2015; Guillabert-
Gourgues et al., 2016). These findings, together with the observations reported above, raise the
possibility that the cell biological effects of noncanonical Wnt signaling are mediated by the Wnt5a-
Ror-dependent degradation of Kif26b. To test this hypothesis, we employed both gain- and loss-of-
function approaches in cultured NIH/3T3 cells, the same cells used for the WRK assays. Western
analysis of the NIH/3T3 cell lines used in the WRK assay showed that GFP-tagged Kif26b protein is
overexpressed relative to endogenous Kif26b in NIH/3T3 cells (Figure 5—figure supplement 1A),
indicating that these cells could be used to assess the effects of Kif26b overexpression on cell
responses. For examining the effects of loss of Kif26b expression on cellular responses in NIH/3T3
cells, we used CRISPR/Cas9-mediated genome editing to generate stable cell lines in which the
expression of Kif26b is knocked out (Figure 5—figure supplement 1B and C). Western blot analysis
verified complete elimination of Kif26b protein relative to a control cell line expressing the Cas9
endonuclease without a guide RNA (Figure 5—figure supplement 1B). We next confirmed that nei-
ther GFP-Kif26b overexpression nor loss of Kif26b affects cell proliferation or survival through mitotic
index quantification and TUNEL staining, respectively (Figure 5—figure supplement 1D–G), indicat-
ing that these NIH/3T3 cell lines could be used to study other possible Kif26b-dependent cellular
responses.
We employed an automated kinetic wound-healing assay that provides a quantitative, integrated
readout of cell morphogenesis such as cell polarization, cell motility and cell adhesion by measuring
the wound closure efficiency of cells under different experimental conditions (Gujral et al., 2014a).
The wound-healing assay has been used previously to assess effects of noncanonical Wnt signaling
(Gujral et al., 2014a, 2014b). Using this assay, we asked if the level of Kif26b expression affects
wound closure efficiency. We found that Kif26b-knockout cells exhibit a decrease in wound closure
efficiency relative to control cells while cell lines overexpressing GFP-Kif26b exhibit an enhanced
rate of wound closure efficiency relative to control cells (Figure 5A,B). These findings suggest that
Kif26b may promote cell migration and are consistent with previous observations in HUVECs where
Kif26b expression was correlated with increased directional cell migration (Guillabert-
Gourgues et al., 2016). Taken together, these findings suggest that by controlling the rate of
Kif26b protein degradation, Wnt5a-Ror signaling regulates cell migration.
Given that exposure of NIH/3T3 cells to Wnt5a acutely downregulates Kif26b protein expression,
we next tested whether this treatment affects the migration of these cells in the wound-healing
assay. We found that Wnt5a treatment decreases the wound closure efficiency of cells overexpress-
ing GFP-Kif26b to a rate approximating that of a control NIH/3T3 cell line in which GFP-Kif26b is not
overexpressed (Figure 5B). This Wnt5a-mediated decrease in wound closure efficiency was corre-
lated with a concomitant decrease in the cellular abundance of Kif26b, suggesting that the specific
degradation of Kif26b could underlie the decrease in wound closure efficiency (Figure 5—figure
supplement 2). Importantly, Wnt5a stimulation of NIH/3T3 cells in which Kif26b expression had
been knocked out via CRISPR/Cas9-mediated genome editing resulted in no decrease in wound clo-
sure efficiency (i.e. had no effect on cell migration) (Figure 5—figure supplement 3), suggesting
that Kif26b expression is required for Wnt5a-dependent changes in cell migration. Taken together,
these results indicate that one key function of Kif26b is to promote cell migration, and that Wnt5a
signaling may control the extent of cell migration by regulating the degradation of the Kif26b
protein.
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In vivo perturbation of Kif26b function produces phenotypes
characteristic of noncanonical Wnt5a-Ror signaling defects
We next sought to determine whether in vivo perturbation of Kif26b during embryonic development
results in phenotypes that are consistent with an important function for Kif26b in Wnt5a-Ror signal-
ing during embryonic development. A previously used approach for determining if a given signaling
molecule functions as part of the noncanonical Wnt pathway was to determine if mis-expression of
the signaling molecule leads to a phenotype similar to that observed when Wnt5a or Rors are mis-
expressed in developing Xenopus or zebrafish embryos (Moon et al., 1993; Hikasa et al., 2002;
Bai et al., 2014; Habas et al., 2001). Mis-expression of either Wnt5a or Ror2 in these embryos
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Figure 5. Wnt5a-Kif26b signaling modulates the migratory behavior of NIH/3T3 cells. (A) Relative wound density of two separate NIH/3T3 cell lines in
which Kif26b expression is knocked out using CRISPR/Cas9 genome editing, and one control Cas9-expressing NIH/3T3 cell line in a kinetic wound-
healing assay. Data are the mean of five independent samples and error bars indicate SEM. t-tests (unpaired) were determined for the following
comparisons: control NIH/3T3 vs. gRNA1, p<0.05; control NIH/3T3 vs. gRNA2, p<0.05. (B) Relative wound density of a GFP-Kif26b expressing NIH/3T3
cell line, treated with or without Wnt5a (0.2 mg/ml, added at the 0 hr time point) and a control NIH/3T3 cell line in a kinetic wound-healing assay. Data
are the mean of five independent samples and error bars indicate SEM. t-tests (unpaired) were determined for the following comparisons: control NIH/
3T3 vs. Kif26b overexpression, p<0.05 (at every time point except the last time point); Kif26b overexpression vs. Kif26b overexpression +Wnt5a, p<0.05
(from 3 to 38 hr time points).
DOI: https://doi.org/10.7554/eLife.26509.019
The following source data and figure supplements are available for figure 5:
Source data 1. (Related to panel A) Relative wound density of two separate NIH/3T3 cell lines in which Kif26b expression is knocked out using CRISPR/
Cas9 genome editing, and one control Cas9-expressing NIH/3T3 cell line in a kinetic wound-healing assay.
DOI: https://doi.org/10.7554/eLife.26509.023
Source data 2. (Related to panel B) Relative wound density of a GFP-Kif26b expressing NIH/3T3 cell line, treated with or without Wnt5a and a control
NIH/3T3 cell line in a kinetic wound-healing assay.
DOI: https://doi.org/10.7554/eLife.26509.024
Figure supplement 1. Overexpression of GFP-Kif26b or knockout of Kif26b expression does not affect the proliferation rate or survival of NIH/3T3 cells.
DOI: https://doi.org/10.7554/eLife.26509.020
Figure supplement 2. Wnt5a downregulates the cellular levels of GFP-Kif26b.
DOI: https://doi.org/10.7554/eLife.26509.021
Figure supplement 3. Wnt5a treatment has no effect on the wound closure efficiency of Kif26b knockout NIH/3T3 cells.
DOI: https://doi.org/10.7554/eLife.26509.022
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produces tissue morphogenesis defects, including defective convergent extension movements and a
shortened or bent body axis, which are characteristic of disrupted noncanonical Wnt signaling. We
therefore asked whether mis-expression of Kif26b protein in developing zebrafish embryos similarly
induced phenotypes typical of abnormal noncanonical Wnt signaling.
To mis-express proteins in the developing zebrafish embryo, we microinjected in vitro-transcribed
mRNA into one-cell stage embryos. Replicating previous reports (Moon et al., 1993; Bai et al.,
2014), microinjection of Wnt5a mRNA caused axis truncation and bending phenotypes (Figure 6A,
B). Strikingly, microinjection of Kif26b mRNA into one-cell zebrafish embryos also caused axis trunca-
tion and bending phenotypes resembling those caused by mis-expression of Wnt5a (Figure 6A,B).
These phenotypes were rarely observed in uninjected embryos or in embryos injected with a nega-
tive control mRNA of similar size, Cas9, indicating that the axis truncation and bending phenotypes
produced by Kif26b mis-expression are specific (Figure 6A,B). Together, these findings suggest that
Kif26b specifically affects morphogenetic movements of cells in developing embryos in a manner
similar to that of Wnt5a or Ror2 and support a model whereby Kif26b functions as part of a nonca-
nonical Wnt5a-Ror regulatory cassette that regulates morphogenetic movements during
embryogenesis.
To investigate further if Kif26b functions as part of the Wnt5a-Ror pathway during mouse devel-
opment, we analyzed the development of primordial germ cells (PGCs), a process previously shown
to require the Wnt5a-Ror pathway (Laird et al., 2011; Chawengsaksophak et al., 2012). During
mouse embryogenesis, PGCs are specified from the epiblast at ~E7.25 and subsequently migrate
through the hindgut and dorsal mesentery to populate the gonadal ridges by E11.5. PGCs that fail
to enter the gonad are eliminated by programmed cell death (McLaren, 2003; Laird et al., 2008).
Loss-of-function mutations in Wnt5a or Ror2 alleles result in a substantial decrease in the number of
PGCs that successfully colonize the gonad at E11.5 as compared to wild-type controls (~75% fewer
in Wnt5a and ~50% fewer in Ror2 mutants) (Chawengsaksophak et al., 2012; Laird et al., 2011),
indicating that Wnt5a-Ror signaling is required for the proper colonization of the gonadal ridges by
migrating PGCs. We reasoned that if Kif26b mediates biological activities of the Wnt5a-Ror pathway
during PGC development, genetic perturbation of Kif26b might also disrupt PGC colonization of the
gonads.
To test this hypothesis, we quantified the number of PGCs in the gonadal ridges of E11.5
Kif26b-/- embryos by whole-mount SSEA1 (a marker of PGCs) staining. The mean number of SSEA1-
positive PGCs in the Kif26b-/- gonads (372.8 ± 74.95, n=4) was decreased significantly to 44.9% of
Kif26b+/+ littermate controls (829.5 ± 88.553, n=2) (Figure 6C,D). The relative similarity of the PGC
depletion phenotypes observed in E11.5 Kif26b-/-, Ror2-/- and Wnt5a-/- mouse embryos suggest that
Kif26b functions in a common signaling pathway with Wnt5a and Ror proteins to orchestrate PGC
development. This experiment, taken together with the mis-expression analysis in zebrafish, provides
in vivo evidence that Kif26b contributes to Wnt5a-Ror signaling in multiple tissues during embryonic
development.
Discussion
Since the seminal discovery that certain Wnt proteins can signal independently of b-catenin-medi-
ated transcription to affect organ and tissue morphogenesis during development (Moon et al.,
1993), few downstream effectors of this signaling system have been identified and validated in bio-
logical systems. In our previous work, we used in vivo mouse genetics to demonstrate that Ror
receptors are essential mediators of a core noncanonical Wnt5a pathway crucial for tissue morpho-
genesis (Ho et al., 2012). In the current study, we integrate conditional mouse genetics with quanti-
tative proteomics to identify new targets of Wnt5a-Ror signaling, and focus on one particularly high
confidence target, Kif26b.
The first indication that Kif26b may mediate Wnt5a/Ror-dependent developmental processes
came from studies in C. elegans. Orthologs of Kif26b (vab-8) and Ror (cam-1) were among the four-
teen genes identified in a forward mutagenesis screen for genes required for the directional migra-
tion of the C. elegans canal-associated neuron (Forrester et al., 1998). C. elegans mutants of vab-8
and cam-1 display similar polarized cell migration and axon guidance defects where cell bodies and
axons that normally move specifically toward the posterior end of the body become abnormally
anteriorly displaced (Wightman et al., 1996; Forrester et al., 1999). In addition, both vab-8 and
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Figure 6. In vivo perturbation of Kif26b expression in zebrafish and mouse embryos induces phenotypes characteristic of Wnt5a-Ror signaling defects.
(A) Representative images showing the effects of Wnt5a and Kif26b mis-expression on zebrafish embryonic tissue morphogenesis.
Microinjection of Wnt5a mRNA did not produce any embryos that were scored as ‘normal’, so the image of an uninjected embryo is shown to represent
normal embryos. (B) Quantification of the effects of Wnt5a and Kif26b mis-expression on zebrafish embryonic tissue morphogenesis. Images were taken
from embryos at 50 hr post fertilization (50 hpf). Data for each experimental condition are pooled from at least three independent injection
experiments. (C) Representative images showing immunofluorescence staining of SEAA1 to mark PGCs that have successfully entered the gonads of
E11.5 Kif26b+/+ or Kif26b-/- mouse embryos. Scale bar represents 100 mm. (D) Quantification of the numbers of PGCs per gonad in E11.5 Kif26b+/+ or
Kif26b-/- mouse embryos. Error bars represent ± SD calculated from independent biological samples (Kif26b+/+, n = 2; Kif26b-/-, n = 4). t-test (unpaired)
was determined for Kif26b+/+ vs. Kif26b-/- (p<0.01).
DOI: https://doi.org/10.7554/eLife.26509.025
The following source data is available for figure 6:
Source data 1. (Related to panel B) The effects of Wnt5a and Kif26b mis-expression on zebrafish embryonic tissue morphogenesis.
DOI: https://doi.org/10.7554/eLife.26509.026
Source data 2. (Related to panel D) Quantification of the numbers of PGCs per gonad in E11.5 Kif26b+/+ or Kif26b-/- mouse embryos.
DOI: https://doi.org/10.7554/eLife.26509.027
Susman et al. eLife 2017;6:e26509. DOI: https://doi.org/10.7554/eLife.26509 16 of 32
Research article Developmental Biology and Stem Cells
cam-1 mutants exhibit a lower penetrance withered-tail (Wit) phenotype reminiscent of the posterior
A-P body axis truncation phenotype seen in Wnt5a or Ror mutant mice (Forrester et al., 1998).
These studies, taken together with the findings in mammalian cells described in this article, suggest
that Wnt5a, Ror and Kif26b proteins may function as part of an evolutionarily conserved pathway
that orchestrates morphogenetic processes during the development of tissues.
Further evidence suggesting Kif26b may function in noncanonical Wnt signaling came from a
recent study that identified Kif26b as a binding partner of Dvl3 in HUVECs (Guillabert-
Gourgues et al., 2016), as Dvl proteins are known targets of Wnt5a-Ror signaling (Ho et al., 2012).
Interestingly, this study demonstrated that Kif26b promotes the directional cell polarization and
growth of HUVECs (Guillabert-Gourgues et al., 2016), consistent with our finding that Kif26b con-
trols the migration of cells.
Our study demonstrates that Wnt5a-Ror signaling regulates Kif26b degradation, thereby influenc-
ing dynamic cellular processes such as the migratory behavior of cells. Moreover, by perturbing
Kif26b function during embryogenesis, we provide in vivo evidence that Kif26b mediates certain bio-
logical effects of the Wnt5a-Ror pathway in body axis elongation and PGC development. Together,
these findings suggest that a Wnt5a-Ror-Kif26b pathway comprises a conserved signaling cassette
crucial for the execution of noncanonical Wnt functions.
Biochemical mechanisms of Wnt5a-Ror-Kif26b signaling
Our observation that Wnt5a-Ror signaling triggers the ubiquitin/proteasome-dependent degrada-
tion of Kif26b demonstrates that UPS-mediated proteolysis is a conserved strategy employed by
both the canonical Wnt/b-catenin and the noncanonical Wnt5a-Ror pathways to control the cellular
abundance of their respective downstream effectors (Figure 7). In addition, we provide further evi-
dence that Fzd and Dvl proteins are shared functional components of both Wnt signaling branches.
Collectively, these observations suggest that the Wnt-Fzd-Dvl signaling module is an ancient and
conserved feature common to multiple Wnt signaling systems. During evolution of the pathway, dif-
ferent signaling branches appear to have adopted additional regulatory mechanisms to achieve sig-
naling and functional specificity. For example, while the Wnt/b-catenin pathway uses the Lrp5/6
receptors in conjunction with Fzd receptors to transmit a canonical Wnt signal across the plasma
membrane, the Wnt5a-Ror pathway uses Ror1/2 receptors, likely also in conjunction with Fzds, to
transmit a noncanonical Wnt signal.
At present, we do not understand the biochemical mechanisms by which Ror and/or Fzd recep-
tors function in the pathway. In the conventional paradigm of receptor tyrosine kinase signaling,
ligand binding induces receptor dimerization or oligomerization, which in turn enhances the intrinsic
kinase activity of the receptor (Lemmon and Schlessinger, 2010). This then triggers receptor auto-
phosphorylation and the subsequent recruitment and/or phosphorylation of downstream cellular
effectors. Whether the Ror family of receptor tyrosine kinases possesses catalytically active kinase
activity, however, is still under debate. It was reported that Wnt5a can stimulate the ability of full-
length Ror2 to phosphorylate a GST-Ror2 kinase domain fusion protein on tyrosine residue(s) in
vitro, and that mutagenesis of conserved tyrosine residues within the tyrosine kinase regulatory loop
of Ror2 impairs the protein’s ability to repress canonical Wnt/b-catenin signaling (Mikels et al.,
2009). Ror1 and Ror2, however, are known to harbor substitutions at amino acid residues generally
believed to be critical for normal kinase function, and recent biochemical and structural studies have
further suggested that the Ror proteins are pseudokinases (Gentile et al., 2011; Artim et al., 2012;
Mendrola et al., 2013). In our phosphoproteomic study, we identified nine distinct Kif26b phos-
phorylation sites on eight unique phosphopeptides, and all these sites mapped to serine or threo-
nine residues (Figure 1—figure supplement 2 and Supplementary file 1). In general, tyrosine
phosphorylation is more dynamic than serine or threonine phosphorylation and tends to be under-
represented in large-scale phosphoproteomic studies (Lombardi et al., 2015). We therefore exam-
ined whether Wnt5a-Ror signaling induces tyrosine phosphorylation of Kif26b in NIH/3T3 cells using
an anti-phosphotyrosine antibody-based affinity pull-down approach. However, under the various
experimental conditions tested, we observed no effect of Wnt5a-Ror signaling on the tyrosine phos-
phorylation of Kif26b (S.S.C. and H.H.H., unpublished data). Thus, whether Ror receptors are active
kinases or pseudokinases, and whether Kif26b is a direct substrate of these receptor tyrosine kinases
will require further investigation.
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It is also possible that phosphorylation of Kif26b by other cellular kinases is involved in Wnt5a-
dependent regulation of Kif26b. Interestingly, a previous study showed that cyclin-dependent kinase
(CDK) phosphorylates Kif26b on multiple serine and threonine sites and that these phosphorylation
events play a critical role in controlling the stability of Kif26b by recruiting the E3 ubiquitin ligase
Nedd4 (Terabayashi et al., 2012). It will be important in future studies to test whether these mecha-
nisms, as well as the additional phosphorylation sites identified in our proteomic screens, are
required for Wnt5a regulation of Kif26b degradation.
The functional interplay between Ror and Fzd receptors is also currently unclear. We have demon-
strated that overexpression of Fzd family members is sufficient to induce Kif26b degradation in NIH/
3T3 cells (Figure 4C,D). Overexpression of Ror2, however, does not have the same effect (E.P.K.
and H.H.H., unpublished observation). These observations raise the possibility that Fzd proteins may
function as the signaling receptors, while Ror proteins may play a modulatory role. This model is also
consistent with our observation that even though endogenously expressed Wnt5a requires Ror1 and
Ror2 expression to downregulate levels of Kif26b (Figures 1B and 2A), high concentrations of exog-
enously added Wnt5a can induce Kif26b degradation in Ror1 and Ror2 double knockout MEFs (M.
W.S., M.E.G. and H.H.H., unpublished data), suggesting that Wnt5a can signal through receptors
other than Rors. A deeper understanding of how Ror and Fzd proteins mediate Wnt5a-Kif26b signal-
ing will require additional biochemical, structural and functional studies.
Our study also directly implicates Dvl proteins in promoting Kif26b degradation (Figure 4E,F)
and further suggests a broader role for Dvl in regulating the stability of Wnt signaling effectors.
Interestingly, during canonical Wnt signaling, Dvl functions to inhibit the degradation of b-catenin,
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Figure 7. Model of Wnt5a-Ror-Kif26b signaling. Schematic of canonical Wnt/b-catenin signaling (A) vs. noncanonical Wnt5a-Ror-Kif26b signaling (B).
See the main text for details.
DOI: https://doi.org/10.7554/eLife.26509.028
Susman et al. eLife 2017;6:e26509. DOI: https://doi.org/10.7554/eLife.26509 18 of 32
Research article Developmental Biology and Stem Cells
whereas during noncanonical Wnt5a signaling, Dvl functions to induce the degradation of Kif26b
(Figure 7). How Dvl transmits pathway-specific signals remains to be elucidated, but it likely involves
differential post-translational modifications such as phosphorylation, differential protein-protein
interactions, or both (Wallingford and Habas, 2005). The identification of Kif26b as a specific target
of Dvl in the noncanonical Wnt signaling branch provides a new inroad to address this important
question.
There is also emerging evidence that noncanonical Wnt signaling may function more generally to
regulate the degradation of multiple proteins. For instance, Wnt5a signaling can induce the degra-
dation of the cell adhesion receptor Syndecan 4 via the proteasome (Carvallo et al., 2010), and non-
canonical Wnt5a and Wnt11 signaling has been associated with the proteasomal degradation of the
focal adhesion molecule Paxillin (Kurayoshi et al., 2006; Iioka et al., 2007). It is possible that Wnt5a
downregulates multiple effector molecules to affect the shape and behavior of cells in a variety of
cell types and developmental contexts.
Cellular and developmental functions of Kif26b
Data from our wound-healing assay suggest that one function of the Wnt5a-Ror-Kif26b axis is to
modulate the migration of cells via Wnt5a-dependent degradation of Kif26b. How might Kif26b
function at a subcellular level to affect cell migration? Mesenchymal cell migration typically involves
four reiterative steps: protrusion of the leading edge, formation and maturation of focal adhesions,
forward translocation of the cell body and finally retraction and de-adhesion of the trailing edge.
Using the GFP-Kif26b NIH/3T3 cell line, we observed that the Kif26b protein is predominantly local-
ized to the trailing edge of the cell, which is most consistent with a role of Kif26b in promoting trail-
ing edge de-adhesion and/or retraction (Figure 3—figure supplement 2D,E; Video 1). This model
is supported by a previously reported binding interaction between Kif26b and Myosin IIb, a key reg-
ulator of cell trailing edge de-adhesion and contractility (Uchiyama et al., 2010). It may also explain
why Wnt5a has been reported in some studies to promote, while in others to suppress, cell migra-
tion (Kremenevskaja et al., 2005; Dissanayake et al., 2007; Nomachi et al., 2008; Enomoto et al.,
2009; McDonald and Silver, 2009; Jiang et al., 2013; Liu et al., 2014; Zhang et al., 2014;
Prasad et al., 2016; Yu et al., 2016; Connacher et al., 2017). It is well established that a delicate
balance of cell adhesive and contractile activities dictates the manner by which cells migrate
(Parsons et al., 2010; Huttenlocher and Horwitz, 2011). Moreover, this balance is likely to be dif-
ferent in different cell types and subject to further regulation by the extracellular environments to
which the cells are exposed. Thus, if the primary function of the Wnt5a-Kif26b signaling axis is to
modulate the strength of cell adhesion and/or contractility at the trailing edge, it could potentially
manifest in opposing cell migratory behaviors depending on the cell types and the culture conditions
used in a given study. Higher resolution imaging studies capable of directly measuring cell adhesion
dynamics and contractile forces will be crucial to understanding how Kif26b functions at the trailing
edge of the cell, or at other subcellular locations, to affect cell migration.
Although we have shown in a wound-healing assay that higher Kif26b levels promote the migra-
tion of NIH/3T3 cells and that Wnt5a signaling negatively regulates the migratory behavior of these
cells via the degradation of Kif26b, it is likely that the signaling dynamics of the Wnt5a-Ror-Kif26b
pathway are actually considerably more complex in vivo. During embryogenesis, migration and other
morphogenetic processes must occur in a highly choreographed fashion where signals that promote
and restrict cell movements are finely tuned in time and space. It is therefore possible that the rela-
tively modest Wnt5a-dependent alteration of Kif26b levels we observed in vitro, as measured across
entire cell populations, does not accurately reflect the dynamic regulation of the pathway that occurs
during the development of tissues. The function of the Wnt5a-Ror pathway may not be simply to
degrade Kif26b constitutively within a cell or tissue, but rather to tune the activity of Kif26b with a
high degree of temporospatial resolution to achieve proper tissue morphogenesis. Indeed, cells are
known to integrate and amplify shallow spatial gradients of extracellular cues into robust changes in
behaviors, such as during axon pathfinding and neutrophil chemotaxis (von Philipsborn and Bast-
meyer, 2007).
The in vivo significance of Kif26b in noncanonical Wnt5a-Ror function is demonstrated by our
gene perturbation experiments. Disruption of Kif26b expression, whether by mis-expression in
zebrafish or by loss-of-function gene ablation in mouse embryos, results in developmental defects
that are similar to those observed when Wnt5a or Ror expression is perturbed. These findings, taken
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together with the observation that loss-of-function cam-1 and vab-8 mutants in C. elegans exhibit
similar neuronal migration and polarization phenotypes (Forrester et al., 1998), support the model
that Wnt5a, Ror and Kif26b comprise a signaling cassette crucial for the morphogenesis of tissues
during development. However, it is important to note that while our in vivo experiments focus on
comparing the gross morphological phenotypes of Kif26b, Wnt5a and Ror mutants, they do not
directly demonstrate that the similarities in the observed phenotypes are caused by common under-
lying mechanisms. Therefore, it remains crucial to characterize the molecular and cellular basis of the
Wnt5a, Ror and Kif26b mutant phenotypes, which will further establish the functional interactions
among these molecules.
It is notable that genetic loss-of-function perturbation of Kif26b expression in mice does not
closely mimic perturbation of Wnt5a or Ror expression in all developmental contexts. For instance,
Kif26b knockout mice do not exhibit the global tissue truncation and craniofacial malformation phe-
notypes seen in Wnt5a and Ror1/2 double mutants (Yamaguchi et al., 1999; Uchiyama et al., 2010;
Ho et al., 2012). In addition, Kif26b knockout mice fail to elicit sprouting of the ureteric bud, result-
ing in kidney agenesis or severe kidney hypoplasia (Uchiyama et al., 2010), whereas Wnt5a or Ror
knockout mice exhibit duplication of the ureteric bud, resulting in pleiotropic kidney defects
(Huang et al., 2014; Nishita et al., 2014; Yun et al., 2014).
There are a number of explanations that might reconcile these seemingly discordant findings in
different biological contexts. First, given the highly complex temporal and spatial dynamics that
Wnt5a-Ror-Kif26b signaling likely undergoes in vivo, it becomes difficult to predict the ultimate phe-
notypes of embryos that constitutively lack the expression of downstream signaling components
across development. Second, Kif26b may not be required in all tissues that undergo Wnt5a-Ror sig-
naling during their morphogenesis. It is likely that other effector molecules may compensate for the
genetic loss of Kif26b in certain developing tissues (Rossi et al., 2015). For instance, the closely
related Kif26a gene is broadly expressed during mouse embryogenesis, and the Kif26a protein is
also a target of Wnt5a-Ror signaling (M.K.S., E.P.K., H.H.H. unpublished data). Thus, one plausible
explanation is that the developmental requirement of Kif26b in tissue extension and craniofacial
morphogenesis may be masked by the continued expression of Kif26a in Kif26b knockout mice. By
RT-qPCR, we verified that Kif26a mRNA is indeed expressed at appreciable levels in both wild-type
and Kif26b knockout E12.5 MEFs, although we did not find evidence that Kif26a transcription is spe-
cifically upregulated in Kif26b knockout MEFs (E.P.K. and H.H.H., unpublished data). Kif26a single
knockout mice also do not exhibit phenotypes typical of noncanonical Wnt5a-Ror signaling defects,
instead manifesting with megacolon from enteric nerve hyperplasia (Zhou et al., 2009). Thus, dis-
covering the full extent of developmental processes regulated by the Kinesin-11 family of proteins,
as well as their functional relationship to the Wnt5a-Ror pathway, awaits a loss-of-function analysis of
both Kif26a and Kif26b together, which may reveal non-overlapping phenotypes not present in
either Kif26a or Kif26b single loss-of-function mutants. Lastly, it is also likely that other signaling
branches apart from Kif26b exist within the Wnt5a-Ror pathway, and that these branches control dis-
tinct cellular processes that do not require the expression of the Kinesin-11 family of proteins. Thus,
building a more complete inventory of the pathway components and understanding how these com-
ponents interact functionally represents an important direction of future investigation.
Materials and methods
Mice
All mouse strains used in the study were described previously: Ror1f/f (Ho et al., 2012), Ror2f/f
(Ho et al., 2012), CAG-CreER (Hayashi and McMahon, 2002, stock # 004453, Jackson Laboratory,
Bar Harbor, ME), Wnt5a-/- (Yamaguchi et al., 1999, stock # 004758, Jackson Laboratory), and
Kif26bf/f (Recuenco et al., 2015, stock # CDB0800K, RIKEN CDB, Japan, http://www2.clst.riken.jp/
arg/mutant_list_file/CDB0800K.html). Kif26b-/- mice were produced by crossing Kif26bf/f mice to a
ubiquitous Cre deleter line (EIIA-Cre [Lakso et al., 1996], stock # 003724, Jackson Laboratory).
Ror1f/f, Ror2f/f and CAG-CreER mice were maintained in a mixed 129 and C57BL/6J background.
Wnt5a-/- and Kif26b-/- mice were maintained in a C57BL/6J background. Wild-type mice are C57BL/
6J. All animals were used according to institutional and NIH guidelines approved by the Institutional
Animal Care and Use Committees at Harvard Medical School and University of California, Davis.
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Cell lines
Primary MEFs were isolated directly from mouse embryos as described (Ho et al., 2012) and used
within three passages. NIH/3T3 Flp-In (R76107, Thermo Fisher Scientific, Hanover Park, IL) and
HEK293T (CRL-3216, ATCC, Manassas, VA) cells were purchased and not re-authenticated. NIH/3T3
Flp-In and HEK293T cells were tested negative for mycoplasma contamination using the Universal
Mycoplasma Detection Kit (30–1012K, ATCC). All cell lines were cultured at 37˚C and 5% CO2 in Dul-
becco’s Modified Eagles Medium (MT15017CV, Corning, Tewksbury, MA) supplemented with 1x
glutamine (25–005 CI, Corning), 1x penicillin-streptomycin (30–002 CI, Corning) and 10% fetal bovine
serum (16000069, Thermo Fisher Scientific).
TMT/MS3 phosphoproteomic screen
Two E12.5 Ror1f/f; Ror2f/f; CAG-CreER/+ embryos were individually dissected and used to derive pri-
mary MEFs. One E12.5 Ror1+/+; Ror2+/+; CAG-CreER/+ embryo was used to derive the control
MEFs. The primary passage of cells derived from each embryo was cultured in a 10-cm plate until
confluent. The primary passage was then split into two 10 cm plates at six million cells per plate (day
0). 24 hr later (day 1), 4-OHT was added to one plate (0.25 mM final concentration), and the drug
vehicle (EtOH) was added to the other plate. On day 2, a media change was performed using fresh
media containing 0.25 mM 4-OHT. On day 3, a media change was performed again, but the final 4-
OHT concentration was reduced to 0.1 mM. On day 4, a media change was performed without 4-
OHT. On day 5, cells were washed once in ice-cold PBS, and cells from each 10-cm plate was
scraped into 1 mL of ice-cold lysis buffer (8 M urea, 75 mM NaCl, 50 mM Tris pH 8.2, 1 mM NaF, 1
mM b-glycerophosphate, 1 mM Na3VO4, 10 mM Na4P2O7, 1 mM PMSF, and cOmplete protease
inhibitor (-EDTA, 04693159001, Roche, Indianapolis, IN). Cells were homogenized by pipetting up
and down using a P-1000 pipettor and then sonicated in a Bioruptor (Diagenode, Denville, NJ; 17 
30 s ON/OFF cycles). Cell lysates were then centrifuged at 40,000 RPM for 20 min at 4˚C. The clari-
fied high-speed supernatants were collected, snap frozen in liquid nitrogen and stored at  80˚C
until the TMT/MS3 analysis was performed. Protein concentrations were determined using BCA
reagents (23225, Thermo Fisher Scientific).
To perform the TMT/MS3 screen, tryptic peptides were prepared from whole cell lysates and the
peptide mixtures from the six experimental conditions were individually labeled with the TMT
reagents, such that reporter ions at m/z of 126, 127, 128, 129, 130 and 131 would be generated in
the tandem spectrometry. Phosphopeptides were enriched by TiO2 chromatography. Liquid chroma-
tography, MS3 tandem mass spectrometry and data analysis were carried out as previously
described (Ting et al., 2011; McAlister et al., 2014; Paulo et al., 2015).
Cloning of mouse Kif26b cDNA
A first-strand cDNA library was generated from MEF total RNA using M-MuLV reverse transcriptase
(M0253S, New England BioLabs, Ipswich, MA) and the d(T)23VN primer according to
the manufacturer’s instructions. This cDNA library was then used as template for PCR amplification
of the Kif26b open reading frame with the following primers: Forward: gatcggccggcctaccatgaattcgg-
tagccggaaataaag; Reverse: gatcggcgcgccttatcggcgcctggaggtgatgtc. The PCR product was subcl-
oned into a modified pCS2+ vector using the FseI and AscI restriction sites. The entire Kif26b open
reading frame was confirmed by sequencing.
Antibodies
Antibodies against Kif26b were generated using a previously described antigen (Uchiyama et al.,
2010). A C-terminal fragment of Kif26b was PCR amplified using the following primers and subcl-
oned into a modified pGEX (28-9546-63, GE Healthcare, Pittsburgh, PA) vector to generate a GST
fusion protein in E. coli. Forward: gatcggccggcctaccatgcgaaacgtgcaagagcctgagtcc; Reverse:
gatcggcgcgccttatcggcgcctggaggtgatgtc. Protein expression was induced in the E. coli strain BL21
(DE3) using IPTG (0.3 mM). To purify the C-terminal Kif26b protein fragment, bacterial pellets were
lysed in STE (150 mM NaCl, 1 mM Tris pH 8.0, 1 mM EDTA) supplemented with protease inhibitors
(04693159001, Roche) and 0.1 mg/ml lysozyme (L-6876, Sigma-Aldrich, St. Louis, MO) and incubated
on ice for 15 min. Just before sonication, DTT was added to a final concentration of 2 mM and pre-
diluted sodium lauroyl sarcosinate (in STE) was added to a final concentration of 10%. Lysates were
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then sonicated in a Bioruptor (5  30 s ON/OFF cycles) and then centrifuged at 60,000 RPM for 30
min at 4˚C. Triton X-100 was added to the supernatant to a final concentration of 3% and incubated
with Glutathione Sepharose 4B beads (17075601, GE Healthcare) for affinity purification. Purified
C-terminal Kif26b proteins were dialyzed in PBS and used for immunization of rabbits.
Antibodies against Ror1 and Ror2 were described previously (Ho et al., 2012). The following anti-
bodies were purchased: rabbit anti-Dvl2 (3216, Cell Signaling Technology, Danvers, MA); rabbit anti-
EGFR (SC-03, Santa Cruz Biotechnology, Dallas, TX); goat anti-Wnt5A (AF645, R&D Systems, Minne-
apolis, MN); mouse anti-a-tubulin (clone DM1A, ab7291, Abcam, Cambridge, MA); chicken anti-GFP
(GFP-1020, Aves Labs, Tigard, OR); rabbit anti-Myosin IIb (3404, Cell Signaling Technology); mouse
anti-GM130 (610822, BD Biosciences, San Jose, CA); rabbit anti-phospho-LRP6 (Ser1490) (2568, Cell
Signaling Technology).
Western blotting
Quantitative western blotting was performed using the Odyssey infrared imaging system (Li-Cor Bio-
sciences, Lincoln, IL) according to the manufacturer’s instructions. Non-saturated protein bands were
quantified using Odyssey software, with the gamma level set at 1. Protein lysates for SDS-PAGE and
western blotting were prepared in 1x or 2x LDS sample buffer (NP0008, Thermo Fisher Scientific)
supplemented with 2-mercaptoethanol (5% final concentration). If BCA assays were required to
quantify the protein lysate concentrations, the lysates were prepared instead in a homemade 1x SDS
sample buffer (50 mM Tris pH 6.8, 2% SDS, 10% glycerol) without bromophenol blue or 2-mercap-
toethanol. Once the protein concentrations were determined and normalized, the lysates were then
mixed with 1/3 volume of 4x SDS sample buffer containing bromophenol blue (0.025%) and 2-mer-
captoethanol (20%). Protein lysates used for Kif26b western blotting were not heated, as the Kif26b
signal weakens substantially after heating, likely due to heat-induced protein aggregation. All other
protein lysates were heated at 90˚C for 5 min before SDS-PAGE and western blotting.
Generation of shRNA targeting Kif26b
The lentiviral vector pLLX3.7 was used to generate recombinant lentiviruses expressing shRNA that
target mouse Kif26b. The following sequences were targeted: gtgccttgcaaatctttat and
gctcgagatacctcagaat.
Generation of stable NIH/3T3 cell lines
To construct the GFP-Kif26b expression plasmid, the eGFP open reading frame was first subcloned
into pENTR-2B (11816-014, Thermo Fisher Scientific), and the full-length mouse Kif26b open reading
frame was subcloned in frame to the C-terminus of GFP. The resulting construct was verified by
sequencing and then recombined with the pEF5-FRT-V5 vector (V602020, Thermo Fisher Scientific)
using LR clonase II (11791100, Thermo Fisher Scientific) to create pEF5-GFP-Kif26b-FRT. The pEF5-
GFP-Kif26b-FRT plasmid was used to generate stable isogenic cell lines using the Flp-In system and
Flp-In NIH/3T3 cell line (Thermo Fisher Scientific). DNA transfection was performed in 10-cm plates
with Genjet In Vitro Transfection Reagent (SL100488; SignaGen Laboratories, Rockville, MD). Cells
that stably integrated the Flp-In constructs were selected using 200 mg/ml hygromycin B and
expanded. A more detailed protocol is described at Bio-Protocol (Karuna et al., 2018).
Lentivirus-mediated protein overexpression
Recombinant lentiviruses were generated using the pLEX_307 (for Dvl1 and all Fzd constructs) or
pLVX-EF1a-mCherry-N1 (for Shisa2) vectors. Both vector systems use the EF1 promoter for driving
transgene expression. pLEX_307 was a gift from David Root (Plasmid 41392, Addgene, Cambridge,
MA) and pLVX-EF1a-mCherry-N1 was purchased (631986, Clontech Laboratories, Mountain View,
CA). The human Dvl1 open-reading frame was cloned by PCR from a HeLa cell cDNA pool. The
mouse Shisa2 open reading frame was PCR amplified from a Shisa2-containing plasmid (a gift from
Xi He). The Fzd open reading frames were PCR amplified from the following Addgene plasmids:
42253, 42259, 42255, 42256, 42267, 42258, 42270 and 42261 (gifts from Chris Garcia and Jeremy
Nathans). The open-reading frames in all lentiviral constructs were verified by sequencing. Lentivi-
ruses were packaged and produced in HEK293T cells by co-transfection of the lentiviral vectors with
the following packaging plasmids: pRSV-REV, pMD-2-G and pMD-Lg1-pRRE (gifts from Thomas
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Vierbuchen). 3 ml or 0.3 ml of the viral supernatants was used to infect WRK reporter cells seeded at
50% confluency in six-well plates. Puromycin selection (0.002 mg/ml) was carried out for 3 days. Cells
from the viral titer that killed a large proportion of cells (60–90%) were expanded and used for
FACS; this ensured that the multiplicity of infection (MOI) is ~1 for all cell lines used in the
experiments.
Generation of Kif26b knockout NIH/3T3 cell lines
The mouse Kif26b gene was mutated by CRIPSR/Cas9-mediated genome editing as according to
(Ran et al., 2013). Briefly, LentiCRISPR V2 (a gift of Feng Zhang, Addgene plasmid 52961) was used
to generate lentiviruses expressing small guide RNAs (sgRNAs). The sgRNA target sequences are:
GCTTACGAGGAGTCGCGCGCCGG; GAACTGTAACGCCCGCTTGGTGG.
Following lentivirus infection and puromycin selection, NIH/3T3 cells were passaged for 3 days to
allow time for mutagenesis to occur. Individual cell clones were picked from cell populations tar-
geted with each of these sgRNAs, expanded and then screened initially by western blotting. Clones
that appeared to lack Kif26b expression were sequenced to confirm genome modification.
Cell proliferation and survival assays
For quantifications of cell proliferation, NIH/3T3 cell lines were plated on glass coverslips 24 hr prior
to fixation. Cells were fixed with 4% paraformaldehyde in Cytoskeleton Buffer with sucrose (10 mM
MES pH 6.1, 138 mM KCl, 3 mM MgCl, 2 mM EGTA, 0.32 M sucrose) for 20 min at room tempera-
ture, permeabilized in TBS-0.5% Triton X-100 for 10 min, then rinsed 3x with TBS-0.1% Triton X-100.
Cells were blocked in Antibody Diluting Solution (AbDil) (TBS-0.1% Triton X-100, 2% BSA, 0.1%
sodium azide) for 30 min at room temperature, then incubated overnight at 4˚C with 1:500 of rabbit
anti-phospho-Histone H3 (Ser10, Mitosis Marker) (#3377, Cell Signaling Technology) diluted in AbDil,
or a no primary antibody control. After five washes in TBS-0.1% Triton X-100, Alexa dye-conjugated
secondary antibodies were added at 1:1000 in AbDil for 45 min at room temperature. After five
washes in TBS-0.1% Triton X-100, coverslips were mounted in DAPI Fluoromount-G (0100–20,
SouthernBiotech, Birmingham, AL). Images of cells were acquired using a 10x objective at equal
exposure, and then analyzed for the presence of nuclear staining of the Mitosis Marker per DAPI-
positive nuclei counted.
For quantifications of cell survival, NIH/3T3 cells lines were plated similarly as for the cell prolifera-
tion assays. TUNEL staining was performed according to the manufacturer’s instructions (In Situ Cell
Death Detection Kit, TMR red, 12156792910, Roche), including a DNase-positive control (M0303S,
New England BioLabs). Images of cells were acquired using a 10x objective at equal exposure, and
then analyzed for the presence of nuclear TUNEL staining per DAPI-positive nuclei counted.
Kinetic wound-healing cell migration assay
Cells were plated on 96-well plates (Essen ImageLock, 4379, Essen Instruments, Ann Arbor, MI).
Wnt-C59 (100 nM final concentration) was added to cells 24 hr prior to wound creation with a wound
scratcher (Essen Instruments). For Wnt5a treatment, recombinant Wnt5a (100 ng/ml final concentra-
tion) was added immediately after creation of wounds. Wound confluence was monitored with Incu-
cyte Live-Cell Imaging System and software (Essen Instruments). Wound closure was observed every
1–2 hr for 48–96 hr by comparing the mean relative wound density of at least four biological repli-
cates in each experiment.
Immunocytochemistry
NIH/3T3 cells were plated at low density and grown on glass coverslips for 24 hr. Cells were rinsed
1x with PBS, then fixed with either ice-cold methanol for 3 min or with 4% paraformaldehyde in
Cytoskeleton Buffer with sucrose for 20 min at room temperature. Cells were then rinsed 3x in PBS,
permeabilized in TBS-0.5% Triton X-100 for 10 min, then rinsed 3x with TBS-0.1% Triton X-100. Cells
were blocked in AbDil for 30 min at room temperature. Primary antibodies were added at the fol-
lowing dilutions in AbDil overnight at 4˚C: chicken anti-GFP at 1:1000, mouse anti-a-tubulin at
1:5000, anti-Myosin IIb at 1:200, and anti-GM130 at 1:50. After five washes in TBS-0.1% Triton
X-100, Alexa dye-conjugated secondary antibodies were added at 1:1000 in AbDil for 45 min at
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room temperature. After five washes in TBS-0.1% Triton X-100, coverslips were mounted in DAPI
Fluoromount-G.
Recombinant proteins and inhibitors
The following recombinant proteins and drugs were purchased: human/mouse Wnt5a (654-WN-010,
R&D Systems); mouse Wnt3a (1324-WN-010, R&D Systems); mouse Dkk-1 (5897-DK-010, R&D Sys-
tems); Wnt-C59 (C7641-2s; Cellagen Technology, San Diego, CA); epoxomicin (A2606,
ApexBio, Houston, TX); PYR-41 (B1492, ApexBio); cycloheximide (C7698-1G, Sigma-Aldrich).
Reverse transcription and qPCR
Total RNA was isolated from MEFs using the PureLink RNA Mini Kit (121830108A, Thermo Fisher
Scientific) according to the manufacturer’s instructions. Isolated RNA was treated with DNase I
(recombinant, RNase-free; 4716728001, Roche) and a cDNA library was synthesized using the cDNA
High Capacity cDNA Reverse Transcription Kit (4368814, Thermo Fisher Scientific). The cDNA was
the source of input for qPCR, using 7900 HT FAST and SYBR Green reagents (4329001, Thermo
Fisher Scientific). The following qPCR primer pairs were used: mKif26b forward, CAAGTACGAG
TGGCTGATGAA; mKif26b reverse, GGACCTGCTCCAAGTCAAAT; b-actin forward, GCTTC
TAGGCGGACTGTTACTGA; b-actin reverse, GCGCAAGTTAGGTTTTGTCAAA.
Flow cytometry
NIH/3T3 cells were plated at a density of 0.09 million/well in a poly-D-lysine-coated 48-well plate. 24
hr after plating, the cells were incubated with 10 nM Wnt-C59 and allowed to reach confluency. 48
hr after plating, cells were stimulated with either Wnt proteins or an equivalent volume of the control
buffer (PBS with 0.1% BSA and 0.5% (w/v) CHAPS) in the presence of 10 nM Wnt-C59 for 6 hr. Cells
were then harvested, resuspended in PBS + 0.5% FBS and analyzed using a flow cytometer (FACS-
can with a 488 nm laser, Becton Dickinson, San Jose, CA). Raw data were acquired with CellQuest
(Becton Dickinson) and processed in FlowJoX (FLOWJO, Ashland, OR). Processing entailed gating
out dead cells, calculation of median fluorescence, percent change of medians, and overlay of histo-
grams. Dose-response curves based on percent change were fitted in MATLAB with the doseRes-
ponse function (written by Richie Smith and publicly available on Matlab File Exchange, File ID #
33604). A more detailed protocol is described at Bio-Protocol (Karuna et al., 2018).
Live imaging
0.05 million cells were plated in a collagen-coated 35-mm glass bottom plate (P35GCOL-0-10-
C, MatTek Corp, Ashland, MA). After adhering to the plate, cells were incubated in culture media
supplemented with 25 mM Hepes and 10 nM Wnt-C59 for 24 hr. Cells were stimulated with 200 ng/
ml recombinant Wnt5a in the presence of 25 mM Hepes and 10 nM Wnt-C59. Cells were imaged
every 10 min for 16 hr, with 500 ms exposure at 40x magnification.
Zebrafish
Wild-type NHGRI-1 fish were bred and maintained using standard procedures (LaFave et al., 2014).
Embryos were obtained by natural spawning and staged as described (Kimmel et al., 1995). All
zebrafish works were approved by the Institutional Animal Care and Use Committee, Office of Ani-
mal Welfare Assurance, University of California, Davis.
In vitro transcribed capped RNAs were prepared using the mMessage mMachine RNA Synthesis
Kit (AM1340, Thermo Fisher Scientific) and purified using the RNeasy Mini Kit (74104, Qiagen, Ger-
mantown, MD) following manufacturers’ instructions.
Microinjection of RNA was performed as described (Jao et al., 2012). In brief, one-cell-stage
embryos from wild-type zebrafish intercrosses were injected with the following amounts of in vitro
transcribed RNA: Cas9, 400 pg; Kif26b, 400 pg; Wnt5a, 150 pg. Pipettes were pulled on a micropi-
pette puller (Model P-97, Sutter Instruments, Novato, CA). Injections were performed with an air
injection apparatus (Pneumatic MPPI-2 Pressure Injector, Eugene, OR). Injected volume (typically ~1
nl) was calibrated with a microruler.
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PGC analysis
For PGC analysis, E11.5 embryos were dissected from timed matings. E0.5 is defined as noon of the
day when the vaginal plug is detected. To expose the gonadal ridges, the abdominal cavity was
opened and the visceral organs removed. The embryos were then cut just anterior to the forelimbs
and just posterior to the hindlimbs. The midsection containing the gonadal ridges were washed
once in cold ( 20˚C) methanol:DMSO (4:1), and then stored in the same fixative solution at  20˚C
until analysis. Genotypes were determined by PCR.
For whole-mount immunofluorescence, fixed embryos were rehydrated and rocked at 4˚C over-
night in PBSMT (PBS with 2% nonfat dry milk and 0.5% Triton X-100) with antibodies to SSEA1
(mouse IgM, MC-480, Developmental Studies Hybridoma Bank, Iowa City, IA, 1:200). Three PBSMT
washes were followed by overnight incubation with secondary antibodies (1:200) and Hoechst
(1:1000) in PBSMT. Embryos were then washed three times in PBS, dehydrated in a series of 5 min
washes in 50%, 70%, 95%, and two times in 100% ethanol while rocking in the dark, and cleared
with methyl salicylate for imaging.
Confocal imaging was carried out at room temperature with a 10x dry objective on a Leica SP5
TCS microscope equipped with 405, 488, 543, 594, and 633 nm lasers. Use of the 10x objective typi-
cally required the addition of a 1.5x digital zoom for optimal visualization of PGCs for quantification.
Files of 1024  1024 pixel images with 2–3 mm distance between z-stacks were captured by a scan-
ner with maximal frame resolution and Leica acquisition software. PGCs were counted on Imaris
imaging software (Bitplane, Belfast, UK) using the Spots module. Spots of 7 mm size in the SSEA1
channel were identified by the software and visually inspected to confirm accuracy. All measure-
ments were exported to Excel (Microsoft, Redmond, WA) for calculations and statistical analyses.
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